Acetylcholinesterase assay may predict cognitive response of Alzheimer patients to eptastigmine treatment

Eur J Clin Pharmacol. 1998 Nov-Dec;54(9-10):809-10. doi: 10.1007/s002280050556.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Acetylcholinesterase / blood*
  • Aged
  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / enzymology*
  • Alzheimer Disease / psychology
  • Cholinesterase Inhibitors / therapeutic use*
  • Cognition / drug effects*
  • Erythrocytes / drug effects
  • Erythrocytes / enzymology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Physostigmine / analogs & derivatives*
  • Physostigmine / therapeutic use
  • Predictive Value of Tests

Substances

  • Cholinesterase Inhibitors
  • physostigmine heptyl
  • Physostigmine
  • Acetylcholinesterase